
S759 Efficacy and Safety of Mirikizumab in Patients With Ulcerative Colitis: 104-Week Results From a Phase 2 Randomized Controlled Trial
Author(s) -
Remo Panaccione,
Brian G. Feagan,
Isabel Redondo,
Trevor Lissoos,
Christian P. Selinger,
Vipin Arora,
Milan Lukáš,
Katsuyoshi Matsuoka,
Toshifumi Hibi
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776568.90890.67
Subject(s) - medicine , ulcerative colitis , gastroenterology , maintenance therapy , surgery , chemotherapy , disease